WINSTROL (Super Micronized Stanozolol) by Meditech is a pharmaceutical-grade water-based injectable stanozolol formulation, distinguished by its super micronized particle size and aqueous suspension delivery system. Stanozolol is a DHT-derived anabolic-androgenic compound with an extensive clinical and pharmacological research history, and its injectable aqueous formulation represents a pharmacokinetically distinct presentation relative to both oral stanozolol tablets and oil-based injectable preparations.
 
✔ Key Research Insights
Studied for its rapid absorption profile attributable to the water-based aqueous suspension and super micronized particle formulation, associated with accelerated systemic availability relative to oil-based injectable preparations in research subjects
Investigated for stanozolol's DHT-derived pharmacological profile, including its documented absence of aromatization to estrogen and high SHBG binding affinity in comparative steroid pharmacology research
Researched for its effects on lean mass parameters, muscle density, and vascular indices in clinical observations, associated with stanozolol's non-estrogenic anabolic profile
Examined for its influence on protein synthesis and nitrogen retention in documented subject populations across anabolic research literature
Documented for its absence of water retention and estrogenic activity, associated with a dry anabolic profile consistently noted in comparative steroid pharmacology research
Manufactured by Meditech to pharmaceutical-grade purity and super micronized formulation standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: WINSTROL
Molecule: Super Micronized Stanozolol
Concentration: 100 mg/mL
Appearance: White aqueous solution
Packing: Sterile 10 mL vial or 10 x 1 mL ampoules
Clinical reference: dosage should be determined by a qualified healthcare professional
 
⚙ How It Works
Stanozolol is a 17α-alkylated DHT-derived anabolic-androgenic steroid administered in this formulation as a super micronized aqueous suspension via intramuscular injection. The super micronization process reduces stanozolol particle size to submicron dimensions, facilitating more consistent suspension stability and absorption characteristics relative to standard micronized preparations in research subjects. As a water-based suspension rather than an oil-based solution, the aqueous formulation is associated in pharmacokinetic research with a more rapid absorption profile following intramuscular administration. Stanozolol does not undergo aromatization to estrogen due to structural modifications in its A-ring, resulting in the documented absence of estrogenic effects including fluid retention across research subject populations. Its high binding affinity for sex hormone-binding globulin (SHBG) has been documented in pharmacological research as a mechanism associated with increased free androgen availability. Primary anabolic effects are mediated through androgen receptor binding in muscle tissue, with downstream influences on protein synthesis and nitrogen retention documented in comparative anabolic-androgenic steroid research literature. The 17α-alkylation present in stanozolol's structure, while enabling oral bioavailability in tablet form, also confers resistance to hepatic metabolism in the injectable formulation, with hepatotoxic considerations documented in clinical literature as relevant to both oral and injectable stanozolol administration.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade purity and super micronized formulation standards
Water-based aqueous suspension with a pharmacokinetically distinct rapid-absorption profile relative to oil-based injectable anabolic preparations
Non-aromatizing DHT-derived compound with a well-documented absence of estrogenic activity in comparative steroid pharmacology research
Available in both multi-dose vial and single-dose ampoule formats for clinical administration flexibility
Widely referenced in anabolic pharmacology and sports medicine research under the stanozolol and Winstrol designations